The global coagulation analyzer market is projected to grow significantly, with an estimated value of USD 4.8 billion in 2024. This growth trajectory is expected to continue, with the market anticipated to exceed USD 9.2 billion by 2034, registering a moderate compound annual growth rate (CAGR) of 6.6%.
Several factors are driving this robust growth in the coagulation analyzer market. The increasing prevalence of blood disorders and the rising awareness of the importance of early diagnosis are leading to higher demand for coagulation testing. Additionally, advancements in technology and the introduction of innovative products are enhancing the efficiency and accuracy of coagulation tests, further contributing to market expansion.
Moreover, the growing number of surgical procedures and the increasing incidence of cardiovascular diseases are expected to boost the demand for coagulation analyzers in hospitals and diagnostic laboratories. As healthcare providers continue to prioritize patient safety and effective treatment outcomes, the importance of reliable coagulation testing will only increase.
When categorized by product type, standalone analyzers are anticipated to take the lead in the global coagulation analyzers market, commanding a substantial share of approximately 56.2% in 2022. This dominance can be attributed to the growing preference of end-users for standalone analyzers over other product variants.
Over the past decade, the healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.
The report offers extensive data sets validating key trends impacting growth in the Coagulation Analysers industry. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of Coagulation Analysers market. With our extensive research and information about the past, current and future market scenario, the Coagulation Analysers industry report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.
Hemostasis analyzers are medical devices used to assess blood clotting function in patients. They measure the time it takes for blood to clot and the strength of the clot that is formed.
There are different types of coagulation analyzers, including manual and automated instruments. Manual coagulation analyzers require trained laboratory personnel to perform the test, while automated analyzers can perform tests automatically without the need for manual intervention.
Competitive Landscape:
The production sphere of coagulation analyzers is marked by the presence of numerous competitors, resulting in a fragmented overall market. Leading companies, in order to meet consumer demand and expand their customer base, are embracing strategic approaches like mergers and acquisitions, partnerships and collaborations, as well as the introduction of innovative products.
Here are notable instances of key strategic developments within the coagulation analyzers market:
- In June 2021, Trivitron Healthcare unveiled two groundbreaking product innovations for HbA1c and Hb variant detection. The NANO H5 and NANO H110, high-performance liquid chromatography analyzers, enable HbA1c detection in less than 3 minutes. These HPLC-based HbA1c analyzers are designed for monitoring conditions such as diabetes, thalassemia, and variations in hemoglobin.
- February 2021 witnessed Siemens Healthineers and Sysmex Corporation renewing their longstanding global distributorship, supply, service agreement, and sales for an extensive portfolio of blood clotting products, including a multi-year extension. This agreement also encompasses Siemens Healthineers’ future distribution of Sysmex’s CN-Series automated blood coagulation analyzers, the CN-3000 and CN-6000, providing cutting-edge, fully automated solutions for mid- and high-volume coagulation testing in laboratories.
- In October 2021, Trivitron Healthcare, in collaboration with Diagon, introduced a new range of coagulation analyzer products tailored for the Indian market, reflecting their commitment to meeting the specific needs of the region.”
Coagulation Analysers Market: Segmentation
By Product:
- Standalone Analyzers
- Table Top Analyzers
- Portable Analyzers
By End User:
- Hospitals
- Clinical Laboratories
- Others
Competitive Analysis
By Prominent Market Players
- Meril Life Sciences
- Robimes India Pvt. Ltd.
- Bpc Biosed Srl
- Hycel, Eurolyser
- Helena Laboratories
- Diagnostica Stago SAS
- Beijing Succeeder Technology Inc.
- A&T Corporation
- Genrui Biotech Inc.
- Bio Group Medical System
- Others
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube